Literature DB >> 7209493

Liver disease in rheumatoid arthritis.

P R Mills, R N MacSween, W C Dick, I A More, G Watkinson.   

Abstract

Patients with active rheumatoid arthritis frequently have hepatosplenomegaly and biochemical features of hepatic disease. A prospective study with liver biopsy has been carried out in a series of 31 rheumatoid arthritis patients with clinical and/or biochemical evidence of hepatic dysfunction. Four of the 31 (13%) were found to have definable chronic liver disease, normal hepatic histology or non-specific reactive changes being found in the remainder. In the large majority of patients the hepatic abnormality in rheumatoid arthritis remains functional and unexplained.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7209493     DOI: 10.1177/003693308002500104

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  5 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

Review 2.  Clinical connection between rheumatoid arthritis and liver damage.

Authors:  Biljana Radovanović-Dinić; Snežana Tešić-Rajković; Valentina Zivkovic; Saša Grgov
Journal:  Rheumatol Int       Date:  2018-04-07       Impact factor: 2.631

3.  Influence of non-steroidal anti-inflammatory drugs and disease activity on serum alkaline phosphatase concentrations in rheumatoid arthritis, osteoarthritis, and polymyalgia rheumatica.

Authors:  A Doube; J Davies; M Davis; P J Maddison
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

Review 4.  Clinical associations between arthritis and liver disease.

Authors:  P R Mills; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

Review 5.  Immune Components of Liver Damage Associated with Connective Tissue Diseases.

Authors:  Aziz A Chentoufi; Youri A Serov; Mansour Alazmi; Kamaldeen Baba
Journal:  J Clin Transl Hepatol       Date:  2014-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.